Elutia Inc ELUT:NASDAQ

RT Quote | USD
Last | 05/22/24 EDT
3.38UNCH (UNCH)
Volume
51,269
52 week range
1.10 - 4.19
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.38
  • 52 Week High4.19
  • 52 Week High Date01/24/24
  • 52 Week Low1.10
  • 52 Week Low Date09/26/23

Key Stats

  • Market Cap82.303M
  • Shares Out24.35M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.64
  • YTD % Change56.48

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close3.38
  • 52 Week High4.19
  • 52 Week High Date01/24/24
  • 52 Week Low1.10
  • 52 Week Low Date09/26/23
  • Market Cap82.303M
  • Shares Out24.35M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta0.64
  • YTD % Change56.48

RATIOS/PROFITABILITY

  • EPS (TTM)-2.56
  • P/E (TTM)-1.32
  • Fwd P/E (NTM)-2.55
  • EBITDA (TTM)-17.138M
  • ROE (TTM)-775.14%
  • Revenue (TTM)25.047M
  • Gross Margin (TTM)42.01%
  • Net Margin (TTM)-197.48%
  • Debt To Equity (MRQ)-43.76%

EVENTS

  • Earnings Date08/12/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Elutia Inc

 

Profile

MORE
Elutia Inc. is a commercial-stage company, which has developed a portfolio of products using both human and porcine tissue. Its portfolio of products spans the Device Protection, Women’s Health and Cardiovascular markets. These products are primarily sold to healthcare providers or commercial partners. In Device Protection, it sells CanGaroo, a biological envelope, that is indicated for use with implantable electronic devices, including cardiac and neurostimulator devices. In...
Kevin Rakin
Chairman of the Board
C. Randall Mills Ph.D.
President, Chief Executive Officer, Director
Matthew Ferguson
Chief Financial Officer
Address
12510 PROSPERITY DRIVE, SUITE 370
Silver Spring, MD
20904
United States

Top Peers

SYMBOLLASTCHG%CHG
ETON
Eton Pharmaceuticals Inc
3.66+0.07+1.95%
CASI
CASI Pharmaceuticals Inc
3.46+0.37+11.97%
CPIX
Cumberland Pharmaceuticals Inc
1.57-0.08-4.85%
BFRI
Biofrontera Inc
1.14+0.02+2.24%
RLMD
Relmada Therapeutics Inc
3.09-0.15-4.63%